Aprotinin in orthotopic liver transplantation.
Bechstein
W O
WO
Department of Surgery, University Clinic Rudolf Virchow, Berlin, Germany.
Riess
H
H
Blumhardt
G
G
Himmelreich
G
G
Jochum
M
M
Gerlach
H
H
Rossaint
R
R
Keck
H
H
Neuhaus
P
P
D000818:Animals; D007611:Aprotinin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000188:drug therapy* / Q000209:etiology; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D002417:Cattle; D005341:Fibrinolysin / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects; D006488:Hemostasis, Surgical / Q000379:methods*; D006801:Humans; D007262:Infusions, Intravenous; D007275:Injections, Intravenous; D007430:Intraoperative Care; D008099:Liver / Q000378:metabolism; D016031:Liver Transplantation / Q000009:adverse effects* / Q000502:physiology; D009926:Organ Preservation; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism; D011229:Preanesthetic Medication; D011446:Prospective Studies; D051381:Rats; D015424:Reperfusion; D012189:Retrospective Studies; D013552:Swine; D013916:Thrombelastography; D000511:alpha-Macroglobulins / Q000378:metabolism
D017395:Plasminogen Activator Inhibitor 1; D000511:alpha-Macroglobulins; C024668:plasmin-alpha(2)-macroglobulin complex; D007611:Aprotinin; D005341:Fibrinolysin